Abstract-Angotensm-converting enzyme (ACE) mhlbltlon alone or m combmatlon with the angotensm type-1 receptor (AT,) antagonist losartan augments clrculatmg levels of the bloactlve peptlde anglotensm-(l-7)
Abstract-Angotensm-converting enzyme (ACE) mhlbltlon alone or m combmatlon with the angotensm type-1 receptor (AT,) antagonist losartan augments clrculatmg levels of the bloactlve peptlde anglotensm-(l- 7) [Ang-(l-7)] Hence, we determined whether Ang-(l-7) contributes to the hypotenslve effects produced by the combined admmlstratlon of hsmopnl and losartan m spontaneously hypertensive rats by blocking the peptide's synthesis with either of two structurally different neprllysm mhlbltors Intravenous admmlstratlon of CGS 24592 (30 mg/kg) to rats m which blood pressure was normalized by 9 days of therapy with hsmopnl and losartan elicited an elevation of mean arterial pressure that was sustained throughout the mfuslon period and for 20 mmutes thereafter The hypertensive response was associated with a 62% reduction m clrculatmg levels of an d no change m plasma angotensm II (Ang II). Intravenous mfuslon of one other neprllysm mhlbltor (SCH 39370, 30 mg/kg) p ro d uced an increase m mean blood pressure of a magnitude smular to that found with CGS 24592 Pretreatment with the nonselective antagonist [Sar,'Thr']-Ang II abolished any additional pressor effects of either neprllysm mhlbltor m spontaneously hypertensive rats treated with hsmopnl or losartan However, neither the endothehn A antagonist BQ123 nor the kmm B2 antagonist HOE 140 had an effect on basal blood pressure or altered the pressor or heart rate effects of the nepnlysm mhlbltors These data suggest that mhlbltlon of Ang-(l-7) formation m rats exposed to the combined blockade of Ang II production and activity 1s associated with a reversal of the antlhypertenslve actions produced by these therapies Thus, endogenous Ang-(l-7) f unctions as a vasodllator hormone m this form of genetic hypertension (Hy2rertension. 1998;31[part 2]:356-361.)
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[Ang-(l-7)], one of several bloactlve end products of the renm-angotensm system, may function as an antihypertensive hormone' by virtue of 'ts potent natnuretlc and diuretic actlons2-4 and vasodepressor effects m the coronary and mesenterlc vascular beds '-' Moreover, low concentrations of enhance the vasodepressor actions of bradykmm m both intact rats"" and isolated canme coronary artery nngs lo The receptor memating the vascular actions of Ang-(l-7) has been tentatively characterized as a non-angotensm type-1 receptor (AT,)/anglotenslon type-II receptor (AT,) subtype " l2 Production of Ang-(l-7) from angotensm I (Ang I) 1s determined by the action of tissue endopeptldases,'3 neutral endopeptldase 24 11 (EC 3 4 24 11, nepnlysm) account for the generatlon of the peptlde m the systenuc and renal clrculatlons l4 Whereas the enzymatic pathway involved m the generation of 1s dlstmct from that of Ang II, anglotensm converting enzyme (ACE) EC 3 4 15 1 cleaves the heptapeptlde mto mactlve products "15 This finding explains the observation m man and animals of a 5-to 25-fold increase m the plasma concentration of Ang-(l-7) dunng chronic treatment with ACE mhlbltors '6-20 Because previous studies suggest that endogenous neutrahzatlon of mlt'gates the antlhypertenslve actions of the combined admmlstratlon of hsmopnl and losartan," we have now explored the effects of acute mhlbmon of synthesis m spontaneously hypertensive rats (SHRs) after their blood pressure was normalized by these therapies The physlologcal consequences of endogenous mhlbltlon were deterrmned by the comparative effect of mfuslon of two specific mhlbltors of nepnlysm at a time when clrculatmg levels of Ang-(l-7) were increased s'gmticantly by chrome therapy with hsmopnl and losartan " Animals Methods Adult male SHRs (12 weeks of age, 350 g) were purchased from Charles River Animals had free access to tap water and rat chow (Purina Mills Inc ) provldmg an Intake of 17 mmol sodium/28 mmol potassmm per 100 g each day The rats were housed under a 12-hour hght/dark cycle m an AAALAC-approved faclhty and were treated for 9 days with hsmoprll (20 mg/kg/24 hours) and losartan (10 mg/kg/24 hours) admmlstered m the drmkmg water, as described previously " Systolic blood pressure was measured m conscious animals by a tall-cuff method (Narco Blo-Systems) (1 mg/kg, n=4) After a 30-mmute penod, SCH 39370 was infused for 10 mmutes to both groups and blood pressure was recorded for an ad&tlonal20 mmutes The dose ofHOE compound used m these expenments blocks the depressor effects of atnal adnumstratlon of bradykmm 2324 Llkewlse, the dose of BQ123 gven to SHRs was shown to prevent the pressor effect of exogenous endothehn 25,26
Assays
Immunoreactlve plasma levels of Ang-l-7 and Ang II were measured by radlolmmunoassay @IA) as described by us elsewhere "" Plasma was extracted on C,, Sep-Pak columns (Waters Corporanon) activated mth acetomtnle, methanol, water, and 0 1% heptafluorobutync acid (HFBA, Plerce)/water Plasma was thawed on Ice, diluted mth 0 1% HFBA and spun m a nucrocentnfuge at 4°C to remove preclpltated material After sample apphcahon, the column was washed with 3 mL of 0 1% HFBA, 20% ACN/O 1% HFBA and the pephdes were eluted m 3 mL of 80% ACN/O 1% HFBA Several ahquots of &ffenng volumes from the eluted frachon were completely evaporated before RIA measurement Peptlde recoveries averaged 75?7% (n=8) using lz51-Ang-(1-7)
Plasma values for and Ang II were not corrected for recovery Plasma concentrations of Ang-(l-7) and Ang II In SHRs, medicated with the comblnatlon of hsmoprtl and losartan for 8 days, 20 minutes after the admimstratlon of either vehicle (n=4) or a neprllysin InhIbItor (CGS 24592, n=6) Data are mean%SEM *p<o1
The effectiveness of CGS 24592 as an mhlbltor of Ang-(l-7) formation was evaluated by measurements of plasma anglotensm levels m treated SHRs gven either the vehicle or the nepnlysm mhlbltor addmona elevation m mean arterial pressure but heart rate increased to an average of 366?10 bpm (Fig 2) A second structurally different nepnlysm mhlbltor was used to evaluate the specificity of the hemodynanuc response of CGS 24592 The carboxyhc ester compound SCH 39370 also displays selective and potent mhlbltory properties against nepnlysm (K,=ll nmol/L) 29 As shown m the upper panel of Fig 3 , treatment with SCH 39370 Increased mean artenal blood pressure from 89?6 mm Hg to 11023 mm Hg (P< 01) The increase m mean blood pressure with SCH 39370 was of a magnitude not &fferent than that obtained with CGS 24592 On the other hand, the pressor response produced by SCH 39370 was associated with significant tachycardla averagmg 406+13 bpm versus 381? 15 bpm (P< 05) Infusion of [Sar,'Thrs]-Ang II before admmlstratlon of SCH 39370 abohshed any additional increase m blood pressure produced by the nepnlysm mhlbltor (Fig 4) but did not block the Increase m heart rate (4452 15 bpm) Thus, admmlstratlon of the competltlve nonselective Ang II receptor blocker obtunded any further elevation m artenal pressure produced by two structurally different nepnlysm mhlbltors having eqmvalent effects on blood pressure but not heart rate The potential contnbutlon of endogenous activation of other vasoactlve hormones due to mhlbltlon of the catalytic activity of nepnlysm was evaluated by mJectlon of selective receptor antagonists of bradykmm and endothelm-A before the mfuslon of a nepnlysm mhlbltor m chronically treated SHRs Injection of HOE 140 had no effect on the baseline mean artenal blood pressure (7923 mm Hg and 80-14 mm Hg before and after HOE 140 mJectlon, respectively) and heart The slmllanty of the effects obtained with the neprllysm mhlbltors and the admmlstratlon of a specific monoclonal Ang-(l- 7) antibody" supports this interpretation As suggested by us previously," the combmatlon of hsmopnl and losartan augments the vasochlator actions of Ang-(l-7) such that mhlbitlon of peptlde synthesis translates mto a partial reversal of the antihypertensive effects of the drug repmen Whether chrome mlubltlon of nepnlysm will be associated with a sustained mlubltlon of Ang-(l- 7) formation and reduced effectiveness of the antlhypertenslve regmen was not determined m these expenments The demonstration that acute neprllysm mhlbmon elevates blood pressure does provide a model to investigate the effects of long-term mhlbitlon However, alternate pathways exist for the generatlon of Ang-(l-7), which may complicate the results of chronic nepnlysm mhlbltlon l3 Nevertheless, m the acute setting of these experiments, our data show that the vasodepressor actions of contributed to the maintenance of the antlhypertenslve action of a chronic therapy resulting from the combmatlon of ACE mhlbltlon and AT, receptor blockade
The mvolvement of other vasoactlve autocolds whose metabolism 1s dependent on the catalytic activity of nepnlysm 1s unlikely Blockade of endothehn and kmm receptors chd not prevent the hemodynamlc response produced by mhlbltlon of nepnlysm Moreover, the effects of [Sar,'Thr*]-Ang II suggests that the vasodepressor actions of are mediated by an angiotensm receptor Our data exclude AT, receptors because SHRs were chronically treated with losartan It 1s also unlikely that high concentrations (~200 pmol/L) may stimulate AT, receptors because the peptlde exhibits such a low affinity for the vascular receptor (ICS,>lpmol/L) 3' Treatment with the AT, antagomst PD 123319 did not block the pressor actions of [Sar,'Thr']-Ang II," whereas we also showed3' that Ang-(l-7) exhibits very low affinity (I&>5 pmol/L) for Ang II bmdmg at the AT2 receptor Our studles33 and those of others34 suggest that interacts with a non-AT,/AT, receptor that 1s sensltlve to the [Sar,'Thrs]-Ang II antagonist
The increases m blood pressure resulting from the two neprllysm inhibitors were blocked by [Sar,'Thr*]-Ang II, however, the antagonist did not attenuate the increase m heart rate Prehmmary studies indicated that the &adrenergc antagonist metoprolol blocked the increase m heart rate but not the pressor response to SCH 39370 (unpublished observations) Addmonal studies will be required to assess the speclficlty of the cardiac rate response produced by mlnbmon of the neprilysm Nepnlysm mlubltors have been used as antlhypertenslve agents with equivocal results 35 In addltlon, mixed ACE and nepnlysm mhlbltors are currently being evaluated for antlhypertensive properties 36 Our findmgs pomt to the potential pitfalls of this therapeutic approach, especially m condmons m which AT, receptor function may be impaired or blocked In view of the wide use of ACE mhlbltors and AT, blockers, the data obtained m these experiments suggest a need for a further understanding of the mechanisms that contribute to the antlhypertenslve actions of these agents.
In conclusion, the results from the present study reinforce the concept that not only do different hormonal systems contribute to the regulation of blood pressure, but peptlde products within a single system such as Ang II and Ang-(l-7) exhibit counter-regulatory actions 37 The vasodepressor actions of m this model of hypertension reveal the complex role that nepnlysm has m the generatlon and metabolism of vasoactlve hormones 18 Kohara
